Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale
- PMID: 30791893
- PMCID: PMC6385440
- DOI: 10.1186/s12883-019-1247-0
Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale
Abstract
Background: Posterior reversible encephalopathy syndrome (PRES) is a complication that occurs during various diseases' treatment. Imaging examination is the gold standard for diagnosis. PRES frequently occurrence in patients with hematological malignancies results in poorer prognosis and higher mortality. We aim to establish a practical and operable scale for early prediction, assessment of the severity of the Posterior Reversible Encephalopathy Syndrome, and timely intervention for better prognosis.
Methods: The scale designed by reviewing the literature and by referring to clinical practice. We assessed the reliability and validity of the scale. Scale-based assessment of children undergoing chemotherapy for acute lymphoblastic leukemia conducted as early warning and intervention for those who may have PRES.
Results: Establishment of Posterior Reversible Encephalopathy Syndrome early warning scoring (PEWS) scale included three parts, as follows: (1) risk factors, including underlying disease, hypertension, Infection, and drug toxicity; (2) clinical features, including high cranial pressure, visual symptoms, seizure, and disturbance of consciousness; and (3) EEG features, including slow wave and epileptiform discharges. Utility assessment of PEWS scale showed that in 57 patients with acute lymphoblastic leukemia, 54 scored less than 10 and none of them detected as PRES. The other two had scores of 12 and 13 both diagnosed with PRES by brain MRI scan.
Conclusions: PEWS scale can predict PRES early. PRES was highly suspected when the score was 10 points and more. Thus, prophylactic intervention can give to improve the prognosis of PRES.
Keywords: Electroencephalogram; Posterior reversible encephalopathy syndrome; Prevention; Scale; Seizure.
Conflict of interest statement
Ethics approval and consent to participate
The research has approved by Chinese PLA General Hospital ethics committee, who permitted us to access patient’s data in all the cooperating hospitals. Informed written consent was obtained from patients’ parents, who gave their consent for their children’s information to be published in this manuscript.
Consent for publication
Written informed consent obtained from the patient’s parents for publication of this article and any accompanying Tables and Figures.
Competing interests
Foundation sponsors of the study played no role in the study design, data collection, data analysis, data interpretation, or writing of report. Authors have no competing interest in relation to the submission. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Li H, Liu Y, Chen J, Tan X, Ye XY, Ma MS, Huang JP, Zou LP: Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome. World J Pediatr : WJP 2015, 11(3):245–249. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
